Haemolytic anaemia due to triose phosphate-isomerase deficiency (Q99650): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A deficiência de triose-fosfato isomerase é um erro inato do metabolismo grave multisistêmico, caracterizado por anemia hemolítica crônica de início precoce, e comprometimento neurológico progressivo que se inicia entre 6 e 30 meses de vida. Outros sinais clínicos podem ser observados, em particular uma paralisia diafragmática que requer ventilação assistida, cardiomiopatia e uma maior susceptibilidade a infecções. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Triose-phosphate isomerase deficiency is a severe multisystem inborn error of metabolism characterised by early-onset chronic haemolytic anaemia, always present, and progressive neurological involvement that starts between 6 and 30 months of age. Other clinical signs can be observed, in particular, diaphragm paralysis that requires assisted ventilation, cardiomyopathy and an increased susceptibility to infections. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/475025488 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_475025488 | |||||||||||||||
| Property / CURIE: CID11:ID_475025488 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_475025488 | |||||||||||||||
| Property / Canary Token: dki-india-ID_475025488 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 16:19, 16 August 2026
Triose-phosphate isomerase deficiency is a severe multisystem inborn error of metabolism characterised by early-onset chronic haemolytic anaemia, always present, and progressive neurological involvement that starts between 6 and 30 months of age. Other clinical signs can be observed, in particular, diaphragm paralysis that requires assisted ventilation, cardiomyopathy and an increased susceptibility to infections.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_475025488 |
||
| English | Haemolytic anaemia due to triose phosphate-isomerase deficiency |
Triose-phosphate isomerase deficiency is a severe multisystem inborn error of metabolism characterised by early-onset chronic haemolytic anaemia, always present, and progressive neurological involvement that starts between 6 and 30 months of age. Other clinical signs can be observed, in particular, diaphragm paralysis that requires assisted ventilation, cardiomyopathy and an increased susceptibility to infections. |
Statements
CID11:ID_475025488
0 references
dki-india-ID_475025488
0 references
Concluído
0 references
15 August 2026
0 references
